Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02561234
Title A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aeglea Biotherapeutics
Indications

Advanced Solid Tumor

lung small cell carcinoma

melanoma

uveal melanoma

Therapies

Pegzilarginase

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.